Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia

NCT02868645 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT02868645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02868645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2016
Completion date
April 10, 2018
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone fibrous dysplasia